1 February 2016 - CADTH has received notice of a pending submission from Genzyme for Cerdelga (eliglustat tartrate) for the treatment of patients with Gaucher disease.

For more details, go to: https://www.cadth.ca/cdr-patient-input-submission?brand_name=Cerdelga&generic_name=eliglustat&indicator=Gaucher%20disease